The 5th annual European Antibody Congress is the Antibody industry's number one congress for addressing the R&D, commercial application and manufacture of antibodies across the whole therapeutic landscape.

http://www.terrapinn.com/2009/antibodyeu/

IBC's antibody conferences offer a preeminent speaker faculty -with more than 100 diverse speakers in Antibody Engineering and Antibody Therapeutics. The IBC Antibody Engineering meeting is now in its 20th year, and it has established an international reputation for the quality of its program during this time.

The 2009 program couples scientific content showcasing basic science research developments with presentations on the progression of industry antibody-based drug products into and through clinical development.

New Antibody Engineering sessions for 2009 include:

- Pre-Conference Workshop: Working with IMGT and other Ab Sequence Databases
- Antibody Repertoires and Responses
- Antibodies in a Complex Environment
- Antibodies - Not Just for Injection
- Antibody Polyspecificity and Single Molecule Imaging
- Bispecific Antibodies and Antibody Combinations
- Expanding our Grasp of Binding Sites in the Human Immune System and their Novel Application
- Exploring the Limits of Tumor Targeting with Molecular Formats
- Engineering Antibodies to Improve Cancer Therapy

Antibody Therapeutics Session for 2009 includes new presentations on:

- Business, Regulatory and Intellectual Property
- Clinical Development for Cancer
- Clinical Development: Alzheimer's and Others
- Clinical Development: Autoimmune Diseases
- Clinical Development: Inflammation and Infection
- Preclinical Development of Antibody Therapeutics

http://www.ibclifesciences.com/antibodyeng/overview.xml